Argan, Inc.

NYSE:AGX Rapport sur les actions

Capitalisation boursière : US$1.8b

Argan Bilan de santé

Santé financière contrôle des critères 6/6

Argan possède un total de capitaux propres de $308.1M et une dette totale de $0.0, ce qui porte son ratio d'endettement à 0%. Son actif total et son passif total sont $726.6M et de $418.5M. L'EBIT de Argan est $44.8M ce qui fait que son ratio de couverture des intérêts -2.5. Elle dispose de liquidités et de placements à court terme de $484.7M.

Informations clés

0%

Ratio d'endettement

US$0

Dette

Ratio de couverture des intérêts-2.5x
Argent liquideUS$484.68m
Fonds propresUS$308.07m
Total du passifUS$418.51m
Total des actifsUS$726.57m

Mises à jour récentes de la santé financière

Pas de mise à jour

Recent updates

Argan: Favorable Long Term Due To Robust Project Pipeline

Oct 15

Argan's (NYSE:AGX) Shareholders Will Receive A Bigger Dividend Than Last Year

Oct 11
Argan's (NYSE:AGX) Shareholders Will Receive A Bigger Dividend Than Last Year

Earnings Tell The Story For Argan, Inc. (NYSE:AGX) As Its Stock Soars 32%

Sep 20
Earnings Tell The Story For Argan, Inc. (NYSE:AGX) As Its Stock Soars 32%

The Market Thinks Argan, Inc. Earnings Were Incredible, I Agree

Sep 08

Argan, Inc. (NYSE:AGX) Not Flying Under The Radar

Aug 03
Argan, Inc. (NYSE:AGX) Not Flying Under The Radar

Argan (NYSE:AGX) Is Experiencing Growth In Returns On Capital

Jul 16
Argan (NYSE:AGX) Is Experiencing Growth In Returns On Capital

An Intrinsic Calculation For Argan, Inc. (NYSE:AGX) Suggests It's 45% Undervalued

Jun 10
An Intrinsic Calculation For Argan, Inc. (NYSE:AGX) Suggests It's 45% Undervalued

After Leaping 25% Argan, Inc. (NYSE:AGX) Shares Are Not Flying Under The Radar

Apr 17
After Leaping 25% Argan, Inc. (NYSE:AGX) Shares Are Not Flying Under The Radar

Argan: Quality Business, Uncorrelated Returns, And Belongs In An All-Weather Portfolio

Apr 09

Argan: 4 Reasons Why This Stock Is A Buy For Long-Term Dividend Investors

Mar 11

Argan: Favorable Supply/Demand Environment And Improved Capital Allocation

Jan 31

A Look At The Fair Value Of Argan, Inc. (NYSE:AGX)

Dec 22
A Look At The Fair Value Of Argan, Inc. (NYSE:AGX)

Argan: Shares Are Cheaper Than They Appear

Dec 11

Argan: Encouraging Near-Term Trends Point To Further Share Price Gains

Nov 08

Argan (NYSE:AGX) Is Increasing Its Dividend To $0.30

Sep 23
Argan (NYSE:AGX) Is Increasing Its Dividend To $0.30

Argan Stock: Recalibrating Expectations

Aug 23

Argan (NYSE:AGX) Has Announced A Dividend Of $0.25

Jun 24
Argan (NYSE:AGX) Has Announced A Dividend Of $0.25

Some Investors May Be Worried About Argan's (NYSE:AGX) Returns On Capital

Jun 08
Some Investors May Be Worried About Argan's (NYSE:AGX) Returns On Capital

Argan, Inc.: Good Growth At Attractive Valuations

Jun 02

Argan (NYSE:AGX) Will Pay A Dividend Of $0.25

Jan 03
Argan (NYSE:AGX) Will Pay A Dividend Of $0.25

Argan: A High Quality Pick For 2023

Dec 26

Time To Worry? Analysts Are Downgrading Their Argan, Inc. (NYSE:AGX) Outlook

Dec 15
Time To Worry? Analysts Are Downgrading Their Argan, Inc. (NYSE:AGX) Outlook

Argan declares $0.25 dividend and increases buyback to $125M

Dec 15

Argan GAAP EPS of $0.56 misses by $0.14, revenue of $117.88M misses by $13.87M

Dec 07

Argan's (NYSE:AGX) Dividend Will Be $0.25

Sep 12
Argan's (NYSE:AGX) Dividend Will Be $0.25

Argan: Assessing If Strong Potential Can Be Realized

Sep 08

Analyse de la situation financière

Passif à court terme: Les actifs à court terme de AGX ( $675.0M ) dépassent ses passifs à court terme ( $415.1M ).

Passif à long terme: Les actifs à court terme de AGX ( $675.0M ) dépassent ses passifs à long terme ( $3.4M ).


Historique et analyse du ratio d'endettement

Niveau d'endettement: AGX est sans dette.

Réduire la dette: AGX n'avait aucune dette il y a 5 ans.

Couverture de la dette: AGX n'a pas de dette, elle n'a donc pas besoin d'être couverte par le flux de trésorerie opérationnel.

Couverture des intérêts: AGX n'a aucune dette, par conséquent la couverture des paiements d'intérêts n'est pas un problème.


Bilan


Découvrir des entreprises saines